On the 25th of November has been published the provisional resolution of candidates with the scoring of the predoctoral candidates of the grant IDIVAL-UC. The candidates consider selected will be the first two candidates with the best punctuation for each research field and the best application evaluated remaining. Candidates selected: • Directors Professors/researchers of […]
Dr. Riancho will be rewarded in the XIV National Research Awards due to his research on “Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis (ALS)” published in the magazine 'Frontiers in Cellular Neuroscience'. On the call has participated in total 16 research works, in which 10 are national projects and […]
Students from the high school Valle de Piélagos de Renedo, IES Valentín Turienzo of Colindres, IES Fuente Fresnedo of Laredo and IES Ría del Carmen of Muriedas have visited the Marques de Valdecilla Research Institute (IDIVAL) due to the celebration of the Science Week. Students visited some of the research laboratories of IDIVAL and had a […]
The cognitive disorder unit of Valdecilla Hospital, under the direction of Pascual Sánchez-Juan, neurologist of Marques de Valdecilla University Hospital and researcher at IDIVAL, has developed a study to evaluate the effects of binge drinking associated with alterations of executive functions. In our analysis we observed that the students who binge drink obtained worse results […]
CHIST-ERA is a consortium of funding organizations with programmes supporting Information and Communication Sciences and Technologies (ICST). The CHIST-ERA consortium is itself supported by the European Union’s Future & Emerging Technologies scheme (FET). Each year, CHIST-ERA launches a call for research proposals in two new topics of emergent scientific importance. This year the topics […]
The next 24th of November will take place the fourth conference of the programme Santander Biomedical Lectures organized by IDIVAL, University of Cantabria and the IBBTEC, given by Giuseppe Del Giudice, Translational Science Leader at GSK Vaccines Srl, Siena, Italy. The session will focus on: “The quest of early biomarkers of vaccine safety and long-term immunity”. […]
